PRMT5 and colorectal neoplasm: Furthermore, studies have shown that Protein arginine methyltransferase 5 (PRMT5)-deficient mouse B cells exhibit dysregulated distribution of RNA m6A modifications, which slows colorectal tumor progression [88].